BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38670741)

  • 1. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
    Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
    Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A convolutional neural network-based, quantitative complete blood count scattergram-mapping framework promptly screens acute promyelocytic leukemia with high sensitivity.
    Liao H; Xu Y; Meng Q; Mao Z; Qiao Y; Liu Y; Zheng Q
    Cancer; 2023 Oct; 129(19):2986-2998. PubMed ID: 37254628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012.
    Thuler LCS; Pombo-de-Oliveira MS
    Ann Hematol; 2017 Mar; 96(3):355-362. PubMed ID: 27752823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of bone marrow samples for discrimination of acute promyelocytic leukemia from other types of acute leukemia using the routine automated hematology analyzer.
    Jang MJ; Choi HW; Lee SY; Lee OJ; Kim HR; Shin JH; Suh SP; Ryang DW; Shin MG
    Int J Lab Hematol; 2014 Oct; 36(5):531-40. PubMed ID: 24410923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears.
    Eckardt JN; Schmittmann T; Riechert S; Kramer M; Sulaiman AS; Sockel K; Kroschinsky F; Schetelig J; Wagenführ L; Schuler U; Platzbecker U; Thiede C; Stölzel F; Röllig C; Bornhäuser M; Wendt K; Middeke JM
    BMC Cancer; 2022 Feb; 22(1):201. PubMed ID: 35193533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side scatter versus CD45 flow cytometric plot can distinguish acute leukaemia subtypes.
    Saksena A; Gautam P; Desai P; Gupta N; Dubey AP; Singh T
    Indian J Med Res; 2016 May; 143(Supplement):S17-S22. PubMed ID: 27748273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry.
    Chen Z; Li Y; Tong Y; Gao Q; Mao X; Zhang W; Xia Z; Fu C
    Int J Hematol; 2016 Mar; 103(3):306-15. PubMed ID: 26759321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-638 in circulating leukaemia cells as a non-invasive biomarker in diagnosis, treatment response and MRD surveillance of acute promyelocytic leukaemia.
    Bai Y; Chen C; Guo X; Ding T; Yang X; Yu J; Yang J; Ruan J; Zheng X; Chen Z
    Cancer Biomark; 2020; 29(1):125-137. PubMed ID: 32568176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia.
    Wang G; Yan G; Sang K; Yang H; Sun N; Bai Y; Xu F; Zheng X; Chen Z
    BMC Cancer; 2022 May; 22(1):481. PubMed ID: 35501730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
    Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
    Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.
    Bonaventure A; Harewood R; Stiller CA; Gatta G; Clavel J; Stefan DC; Carreira H; Spika D; Marcos-Gragera R; Peris-Bonet R; Piñeros M; Sant M; Kuehni CE; Murphy MFG; Coleman MP; Allemani C;
    Lancet Haematol; 2017 May; 4(5):e202-e217. PubMed ID: 28411119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
    Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
    Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative Group.
    Pulsoni A; Stazi A; Cotichini R; Allione B; Cerri R; Di Bona E; Nosari AM; Pagano L; Recchia A; Ribersani M; Rocchi L; Veneri D; Visani G; Mandelli F; Mele A
    Eur J Haematol; 1998 Nov; 61(5):327-32. PubMed ID: 9855248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
    Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
    Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illness severity assessment of older adults in critical illness using machine learning (ELDER-ICU): an international multicentre study with subgroup bias evaluation.
    Liu X; Hu P; Yeung W; Zhang Z; Ho V; Liu C; Dumontier C; Thoral PJ; Mao Z; Cao D; Mark RG; Zhang Z; Feng M; Li D; Celi LA
    Lancet Digit Health; 2023 Oct; 5(10):e657-e667. PubMed ID: 37599147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL)).
    Küley-Bagheri Y; Kreuzer KA; Monsef I; Lübbert M; Skoetz N
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011960. PubMed ID: 30080246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated prediction of acute promyelocytic leukemia from flow cytometry data using a graph neural network pipeline.
    Cox AM; Kim D; García R; Fuda FS; Weinberg OK; Chen W
    Am J Clin Pathol; 2024 Mar; 161(3):264-272. PubMed ID: 37878540
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.